Sinclair SH - Search Results

1

Screening athletes with Down syndrome for ocular disease.

Gutstein W, Sinclair SH, North RV, Bekiroglu N. Gutstein W, et al. Among authors: sinclair sh. Optometry. 2010 Feb;81(2):94-9. doi: 10.1016/j.optm.2009.09.017. Optometry. 2010. PMID: 20152783

2

Central field perimetry of discriminated targets: I. Results for normal individuals using high-contrast targets.

Yavuz GA, Unver YB, Bekiroglu N, Presti P, Sinclair SH. Yavuz GA, et al. Among authors: sinclair sh. Eye (Lond). 2009 Nov;23(11):2082-9. doi: 10.1038/eye.2009.177. Epub 2009 Jul 17. Eye (Lond). 2009. PMID: 19648898

3

Relationships between clinical measures of visual function and anatomic changes associated with bevacizumab treatment for choroidal neovascularization in age-related macular degeneration.

Unver YB, Yavuz GA, Bekiroğlu N, Presti P, Li W, Sinclair SH. Unver YB, et al. Among authors: sinclair sh. Eye (Lond). 2009 Feb;23(2):453-60. doi: 10.1038/eye.2008.349. Epub 2008 Nov 28. Eye (Lond). 2009. PMID: 19039333

4

Interactive, computer-based, self-reported, visual function questionnaire: the PalmPilot-VFQ.

Unver YB, Yavuz GA, Sinclair SH. Unver YB, et al. Among authors: sinclair sh. Eye (Lond). 2009 Jul;23(7):1572-81. doi: 10.1038/eye.2009.101. Epub 2009 May 29. Eye (Lond). 2009. PMID: 19478821

5

Entoptic phenomenon following pars plana vitrectomy caused by retained preretinal gel.

Yavuz GA, Unver YB, Sinclair SH. Yavuz GA, et al. Among authors: sinclair sh. Ophthalmic Surg Lasers Imaging. 2009 Mar-Apr;40(2):188-91. doi: 10.3928/15428877-20090301-01. Ophthalmic Surg Lasers Imaging. 2009. PMID: 19320311

6

Effects of intravitreal erythropoietin therapy for patients with chronic and progressive diabetic macular edema.

Li W, Sinclair SH, Xu GT. Li W, et al. Among authors: sinclair sh. Ophthalmic Surg Lasers Imaging. 2010 Jan-Feb;41(1):18-25. doi: 10.3928/15428877-20091230-03. Ophthalmic Surg Lasers Imaging. 2010. PMID: 20128565

7

Laser treatment of diabetic macular edema: comparison of ETDRS-level treatment with threshold-level treatment by using high-contrast discriminant central visual field testing.

Sinclair SH, Alaniz R, Presti P. Sinclair SH, et al. Semin Ophthalmol. 1999 Dec;14(4):214-22. doi: 10.3109/08820539909069540. Semin Ophthalmol. 1999. PMID: 10758222

8

Anti-VEGF effects of intravitreal erythropoietin in early diabetic retinopathy.

Zhang J, Hu LM, Xu G, Wu Y, Shen J, Luo Y, Zhong Y, Sinclair SH, Yanoff M, Li W, Xu GT. Zhang J, et al. Among authors: sinclair sh. Front Biosci (Elite Ed). 2010 Jun 1;2(3):912-27. doi: 10.2741/e151. Front Biosci (Elite Ed). 2010. PMID: 20515763 Free article.

9

Prophylactic treatment of age-related macular degeneration report number 1: 810-nanometer laser to eyes with drusen. Unilaterally eligible patients.

Friberg TR, Musch DC, Lim JI, Morse L, Freeman W, Sinclair S; PTAMD Study Group. Friberg TR, et al. Ophthalmology. 2006 Apr;113(4):622.e1. doi: 10.1016/j.ophtha.2005.10.066. Ophthalmology. 2006. PMID: 16581422 Clinical Trial.

10

Diabetic retinopathy: treating systemic conditions aggressively can save sight.

Sinclair SH, Malamut R, Delvecchio C, Li W. Sinclair SH, et al. Cleve Clin J Med. 2005 May;72(5):447-54. doi: 10.3949/ccjm.72.5.447. Cleve Clin J Med. 2005. PMID: 15929458 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

77 results

Search Page

Filters